Approval · Notice of Compliance 17120 · 2015
VANIQA: Notice of Compliance 17120
Issued July 22, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17120
- Date
- July 22, 2015
- Company
- Cipher Pharmaceuticals Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification numbers
- Therapeutic class
- Hair growth inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VANIQA | 02243837 | Marketed |
Medicinal ingredients
- EFLORNITHINE HYDROCHLORIDE 13.9 PER